Interaction Checker

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Elbasvir/grazoprevir - a new addition to the comedication list

Thursday 11 February 2016

Zepatier, a fixed dose combination product containing elbasvir and grazoprevir has been approved by the FDA for the treatment of hepatitis C infection.
Elbasvir/grazoprevir has been added to the antiviral class of comedications and is now available on the web and app versions of the interaction charts.
Awards and commendations
bma-foundation-for-medical-research british-medical-journal-2018 queens_aniversary_prize_2017 rcp-excellence-patient-care-awards-2017
building_better_healthcare_awards_2016 healthline-best-HIV-and-AIDS-apps-of-2016